Efficacy And Safety Of Sorafenib In Patients In The Asia-Pacific Region With Advanced Hepatocellular Carcinoma: A Phase III Randomised, Double-Blind, Placebo-Controlled Trial.

·2008·DOI

Role in the Field

Abstract

Citations

4,602

Year

2008

PageRank

4.6 / 10

Relative influence (log-scaled)

Efficacy And Safety Of Sorafenib In Patients In The Asia-Pacific Region With Advanced Hepatocellular Carcinoma: A Phase III Randomised, Double-Blind, Placebo-Controlled Trial. | Manumap